Table 2.
Variable | Group | ||||
---|---|---|---|---|---|
Reference group (n = 1402) Mean ± SD |
Arterial Disease group (n = 502) Mean ± SD |
p-value arterial disease vs. reference |
Venous Disease group (n = 195) Mean ± SD |
p-value venous disease vs. reference |
|
Lag Time [min] | 4.94 ± 1.03 | 6.56 ± 3.71 | < 0.0001 | 6.50 ± 3.95 | < 0.0001 |
ETP [nM.min] | 1105.0 ± 237.4 | 1045.0 ± 360.8 | 0.00056 | 1048.5 ± 423.3 | 0.070 |
Peak Height [nM] | 118.37 ± 54.81 | 113.09 ± 55.36 | 0.067 | 113.50 ± 60.32 | 0.29 |
Factor II [%] | 116.9 ± 17.6 | 108.7 ± 28.9 | < 0.0001 | 104.8 ± 32.7 | < 0.0001 |
Factor V [%] | 116.6 ± 18.5 | 118.9 ± 19.9 | 0.024 | 118.4 ± 22.0 | 0.29 |
Factor VII [%] | 111.1 ± 21.6 | 108.3 ± 31.2 | 0.056 | 107.2 ± 34.8 | 0.12 |
Factor VIII [%] | 115.3 ± 33.1 | 136.3 ± 40.2 | < 0.0001 | 140.1 ± 46.5 | < 0.0001 |
Factor IX [%] | 106.3 ± 14.4 | 110.9 ± 21.7 | < 0.0001 | 107.4 ± 24.3 | 0.53 |
Factor X [%] | 113.10 ± 19.09 | 105.59 ± 33.53 | < 0.0001 | 103.87 ± 38.95 | 0.0013 |
Factor XI [%] | 106.8 ± 18.2 | 110.2 ± 19.8 | 0.00090 | 112.6 ± 19.4 | < 0.0001 |
Factor XII [%] | 105.6 ± 24.3 | 102.1 ± 24.9 | 0.0071 | 105.5 ± 24.7 | 0.98 |
vWF [%] | 103.1 ± 35.5 | 127.7 ± 45.0 | < 0.0001 | 127.7 ± 48.3 | < 0.0001 |
Protein C [%] | 113.3 ± 17.2 | 111.3 ± 26.1 | 0.097 | 110.2 ± 28.3 | 0.13 |
Protein S [%] | 95.1 ± 16.4 | 100.3 ± 24.1 | < 0.0001 | 93.4 ± 24.7 | 0.34 |
Antithrombin [%] | 102.8 ± 9.8 | 98.1 ± 11.9 | < 0.0001 | 100.8 ± 10.7 | 0.014 |
TFPI Activity [U/mL] | 1.57 ± 0.53 | 1.63 ± 0.57 | 0.040 | 1.64 ± 0.52 | 0.084 |
Fibrinogen [mg/dL] | 331 ± 66 | 395 ± 95 | < 0.0001 | 391 ± 95 | < 0.0001 |
Presented are thrombin generation parameters and coagulation factors in the reference, arterial disease and venous disease subsample
Abbreviations: SD standard deviation, vWF Von Willebrand Factor, TFPI Tissue Factor Pathway Inhibitor